Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570–83.
Narang V, Kaur R, Garg B, et al. Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis. Intest Res. 2018;16:55–61.
Cushing KC, Tan W, Alpers DH, et al. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Aliment Pharmacol Ther. 2020;51:347–55.
Geboes K, Riddell R, Ost A, Jensfelt B, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404–9.
Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174–8.
Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, et al. Development and validation of the nancy histological index for UC. Gut. 2017;66:43–9.
Mosli MH, Feagan BG, Zou G, et al. Development and validation of a histological index for UC. Gut. 2017;66:50–8.
Ozaki R, Kobayashi T, Okabayashi S, et al. Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa. J Crohns Colitis. 2018;12:1288–94.
Mosli MH, Feagan BG, Zou G, et al. Reproducibility of histological assessments of disease activity in UC. Gut. 2015;64:1765–73.
Gupta A, Yu A, Peyrin-Biroulet L, et al. Treat to target: the role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19:1800–13.
Lin TY, Dollär P, Girshick T, et al. Feature pyramid networks for object detection. In Proceedings of the IEEE conference on computer vision and pattern recognition. 2017 (pp 2117–2125)
Yakubovskiy P, Segmentation models pytorch. 2020. https://github.com/qubvel/segmentation_models.pytorch. Accessed 3 March 2021.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
Noffsinger AE. Fenoglio-preiser’s gastrointestinal pathology. 4th ed. Philadelphia: Wolters Kluwer; 2017. p. 725.
Shepherd NA, Warren BF, Williams GT, et al. Morson and dawson’s gastrointestinal pathology. 5th ed. Oxford: Wiley-Blackwell; 2012. p. 577.
Strugala V, Dettmar PW, Pearson JP, et al. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and crohn’s disease. Int J Clin Pract. 2008;62:762–9.
van der Post S, Jabbar KS, Birchenough G, et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut. 2019;68:2142–51.
Johansson ME, Gustafsson JK, Holmen-Larsson J, et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281–91.
Gersemann M, Becker S, Kübler I, et al. Differences in goblet cell differentiation between crohn’s disease and ulcerative colitis. Differentiation. 2009;77:84–94.
Bressenot A, Salleron J, Bastien C, et al. Comparing histological activity indexes in UC. Gut. 2015;64:1412–8.
Jauregui-Amezaga A, López-Cerón M, Aceituno M, et al. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study. Inflamm Bowel Dis. 2014;20:1187–93.
Yoon H, Jangi S, Dulai PS, et al. Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis. Gastroenterology. 2020;159:1262-1275.e7.
留言 (0)